Chimeric Antigen Receptor T-cells for The Treatment of AML Expressing CLL-1 Antigen
NCT04219163
·
clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Acute Myeloid Leukemia
Interventions
BIOLOGICAL:
CLL-1.CAR T cells
Sponsor
Baylor College of Medicine
Collaborators
[object Object]
[object Object]